Building capacity for equitable cervical cancer screening and follow-up in an FQHC–NCI cancer center partnership: a mixed-methods study of multilevel implementation determinants Authors: Jennifer Tsui, Samantha Garcia, Michelle B Shin, Kathy Lui, Angela Ching, Gene Hui, Morgan Gill, X Mona Guo, Chanita Hughes Halbert, Lourdes Baezconde-Garbanati, Jack Cheng Published: 2026 ABSTRACT AbstractIntroductionMultilevel barriers to cervical cancer screening and follow-up contribute to persistent inequities in cancer burden in communities that face social and structural disadvantage. Partnerships between NCI-designated cancer centers and Federally Qualified Health Centers (FQHCs) can strengthen primary care capacity to improve cervical cancer screening uptake, timely follow-up care, and regional cancer control.MethodsThrough the HRSA Accelerating Cancer Screening program, the USC Norris Comprehensive Cancer Center partnered with Chinatown Service Center, a multi-site FQHC serving Chinese and Hispanic patients in Los Angeles, to improve access to cervical cancer screening, follow-up and referral to treatment. Guided by the Consolidated Framework for Implementation Research, we conducted a mixed-methods assessment that combined surveys and semi-structured interviews with clinic team members to identify multilevel determinants of care processes and implementation priorities and a medical chart review to assess screening follow-up patterns among patients screened between January 2020 and March 2023.ResultsSurveys (n = 24) showed providers had higher knowledge of screening guidelines (67% vs. 49%; p < 0.05) and greater confidence discussing cervical cancer with patients (94% vs. 36%; p < 0.05) than clinic staff, indicating opportunities for staff training. Qualitative interviews (n = 23) identified inner setting barriers such as provider variation screening guidelines adherence and lack of tracking tools for screening follow-up. Outer setting barriers included wait times for referrals, transportation barriers, and difficulty accessing specialists through managed care networks. Inner setting factors included FQHC strengths in community partnerships that can contribute to addressing cultural barriers and patients’ social needs. Building capacity for tracking cervical cancer screening results was needed. At the individual level, many patients requested gender and language-concordant providers for screening. Older patients and those not sexually active often declined screening. Medical chart reviews (n = 50) identified opportunities to improve closed-loop communication with specialists and to systematically document screening results and risk-based follow-up.DiscussionWe found that cervical cancer screening and follow-up strategies should prioritize strengthening workforce capacity, building infrastructure for tracking screening and follow-up, and improving referral coordination. Strengthening partnerships between FQHCs and comprehensive cancer centers offers a scalable approach to disseminating and sustaining innovations in cancer screening, with potential to improve access, adherence, and early detection across populations.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12875-026-03387-2.Keywords: Cervical cancer, Cervical cancer screening, Federally Qualified Health Centers, Early detection, Screening follow-up, Multilevel interventions Introduction Human papillomavirus (HPV) vaccination and routine screening with Pap and HPV testing can prevent up to 93% of cervical cancers [1]. Timely follow-up of abnormal screening results and treatment of precancerous lesions are highly effective in preventing cervical cancer disease progression. Thus, with high population-level coverage of HPV vaccination, guideline-concordant screening, and timely follow-up and treatment, elimination of cervical cancer is within reach [2–4]. However, the American Cancer Society estimates 13,800 new cases of invasive cervical cancer and 4,360 deaths from cervical cancer occurred in 2025 in the United States (US) [5]. While cervical cancer incidence and mortality in the US have declined substantially over the past several decades [5], recent trends show minimal improvements among medically underserved populations [6]. Persistent disparities in cervical cancer burden reflect structural barriers to healthcare access and limited implementation of evidence-based strategies to support screening and follow-up needs, particularly among low-income, uninsured and underinsured patients seeking care in safety-net primary care settings [7, 8]. The United States Preventive Services Task Force (USPSTF) recommends routine cervical cancer screening with a Pap test every 3 years for average-risk women aged 21 to 29 years and, for women aged 30 to 65 years, either a Pap test every 3 years, primary HPV testing every 5 years, or co-test with HPV and Pap test every 5 years [9]. More recently, the American Cancer Society and the Health Resources and Services Administration (HRSA) issued new guidelines to include HPV self-sampling as a viable screening modality for average-risk women [10, 11]. In 2023, nearly 76% of women in the U.S. were up-to-date with cervical cancer screening, despite Healthy People 2030 goal of 79.2% [12, 13]. Patients in Federally Qualified Health Centers (FQHCs), community-based clinics that receive federal funding to provide comprehensive, high-quality primary care services to medically underserved populations, are less likely to receive up-to-date screening compared to non-FQHC patients [14–16]. In California, only 58% of women in FQHCs received a Pap test within 3 years or HPV test within 5 years in 2022 [17] and 66% of adolescents ages 13–17 have received all recommended HPV vaccine doses in 2024 [18]. Given rapid changes in HPV vaccination and cervical cancer screening guidelines over the past two decades, it is critical to build capacity within FQHC clinic teams to ensure providers and staff can address system and patient challenges [19, 20]. Few studies have examined provider-level and system-level cervical cancer screening and follow-up processes within FQHC settings after the COVID-19 pandemic. Emerging data indicates that substantial proportions of patients in FQHC settings remain under-screened for cervical cancer [21]. Although multiple evidence-based interventions (EBIs) have demonstrated effectiveness in improving cancer screening and follow-up, including patient navigation, provider and clinic staff training on changing guidelines, workflow improvements and appointment reminders [22, 23], their impact relies on scaled implementation and adaptation in diverse settings. Furthermore, clinic processes for follow-up to abnormal screening results, including adherence to follow-up guidelines, notifying patients of results, and coordinating needed referrals, may comprise of separate facilitators and barriers than screening. Identifying evidence-based interventions and strategies to improve cervical cancer screening, follow-up and referral in FQHCs require systematic assessment and understanding of community needs and barriers as well as building capacity and partnerships with payers and health system partners that align with the local context. In this study, we focus on an urban multisite FQHC primarily serving Asian American and Hispanic communities in Los Angeles. We aim to identify determinants of cervical cancer screening, follow-up, and referral to inform implementation needs for cervical cancer screening improvement for this patient population. Methods Setting and target population This study developed through a partnership supported by the Health Resources and Services Administration (HRSA) Accelerating Cancer Screening (AxCS) Program between the USC Norris Comprehensive Cancer Center (USC NCCC) and Chinatown Service Center. The AxCS Program supports community health centers in increasing equitable access to cancer screening, follow-up, and treatment through education, case management, outreach, and other enabling services in partnership with NCI-designated cancer centers. Chinatown Service Center (CSC), a multi-site FQHC, is the largest community-based Chinese American health and human service organization in Southern California, providing comprehensive medical, behavioral health, social services, dental services and other programs, primarily serving Chinese American, other Asian American and Hispanic communities in East and Central Los Angeles. CSC serves approximately 20,000 unique patients per year across 7 clinics, with over 95% of patients who are racial/ethnic minority and 68% of patients having limited English proficiency. Services are available in a variety of dialects, including Cantonese, Mandarin, Toisan, Chiu Jou, Vietnamese, Spanish, and Khmer (Cambodian). Cervical cancer screening rates ranged between 51% and 73% between 2020 and 2024 based on Health Center Program Uniform Data System (UDS) data. CSC is located within five miles of USC NCCC but had not previously collaborated closely with the cancer center on cancer-focused initiatives. The mission of USC NCCC is to reduce and eliminate cancer health disparities among the populations represented in the greater Los Angeles and Southern California region. Mixed-methods design We conducted a convergent mixed-methods assessment between June and December 2023 to understand cervical cancer screening, follow-up, and referral processes across the multi-site FQHC system and implementation needs for evidence-based interventions and strategies to support screening and follow-up improvement through qualitative interviews, quantitative surveys and electronic medical records. Data collection and analysis for interviews and surveys were guided by the updated Consolidated Framework for Implementation Research (CFIR) framework [24]. We collected quantitative survey data, qualitative interview findings, and electronic medical chart reviews of patients concurrently during the study period to obtain a comprehensive assessment of cervical cancer screening, follow-up, and referral processes within the FQHC setting and to inform needed interventions and implementation strategies to support cervical cancer screening processes from both clinic team perspectives as well as from patient data. Quantitative data characterized knowledge, confidence, and patterns of guideline concordance, while qualitative data contextualized these findings by elucidating multilevel barriers and facilitators influencing care delivery. Integration occurred through joint interpretation, comparison, and synthesis of results across data sources. This study was approved by the University of Southern California Institutional Review Board (UP-23-00185). Surveys Surveys were conducted in June 2023 during a monthly FQHC administrative meeting that included physicians (i.e., MD/DO), advanced practice providers (i.e., Nurse Practitioners, Physician Assistants) and clinic staff (i.e., medical assistants, nurses). The 22-item self-administered survey (see Supplementary File) assessed clinic team members’ knowledge, confidence in addressing patient concerns about cervical cancer screening, and perspectives on opportunities to implement evidence-based interventions to improve screening and follow-up of screening results in the clinic setting. Response options for confidence questions were coded: (1) not confident; (2) slightly confident; (3) confident; (4) very confident. Survey participants were entered into a raffle and two were selected to receive a $25 gift card. Descriptive frequencies were used to summarize survey items and Fisher’s exact tests were performed to calculate differences between participant roles and demographics. P-values of 0.05 or less were considered statistically significant. Qualitative interviews Between June and September 2023, FQHC system leaders, providers (physicians and APPs), and clinic staff were identified collaboratively with clinic leaders for participation in qualitative interviews to provide perspectives on existing cervical cancer screening and follow-up processes and opportunities for improvement. Interview guides were informed by updated CFIR and consisted of open-ended questions focusing on facilitators, barriers, and experiences with providing cancer prevention services, cervical cancer screening, follow-up care and referral, navigation services, and transitioning patients to treatment (see Supplementary File). Two graduate-level study team members conducted 30-minute one-on-one interviews, in-person or virtually, with participants. Interviews were audio recorded. Participants received a $25 gift card. All interviews were transcribed and de-identified. Qualitative data analysis was guided deductively by updated CFIR framework domains [24] covered in the interview guide as well as inductively through emergent themes. Core members of the research team, comprised of those with expertise in cervical cancer control, health services research, and health equity, met bi-weekly to discuss emergent themes and develop appropriate codes through an immersion/crystallization process. Four independent coders from the core team thoroughly read and coded all interview transcripts using the codebook. We used Miles and Huberman’s process of creating matrices to display the data for comparative analyses [50] where one team member extracted all data relevant to each code. The team continued to meet to discuss discrepant coding and modify the codebook accordingly throughout the analysis period. All coders met after coding each wave of stakeholder groups to discuss major themes and finalize the analysis of interviews. Discrepancies in the interpretation of codes among coders were discussed and resolved by majority agreement [25]. All coding was conducted using NVivo version 1.7.1 [26]. Medical chart reviews We conducted a retrospective chart review, using data from the FQHC’s NextGen Healthcare electronic health record (EHR) system, of a subset of female patients aged 21–65 with ≥ 1 cervical cancer screening order between January 1, 2020, and March 31, 2023, to characterize patterns of cervical cancer screening and processes of care; for example, whether they received screening within guideline recommended timelines and identify healthcare system opportunities to improve connection with follow-up care for abnormal results. Patient charts, pathology and HPV test results, reviewing provider notes for patient encounters, and checking for communication with patients and specialists, as well as results of follow-up screenings, were reviewed by a medical student and two nurse-trained research team members. Patients were grouped as average risk (no prior abnormal screening results), average-to-high risk (abnormal screening result documented for the first time), and high risk (history of ≥ 1 abnormal result) based on cervical screening results and then a random sample of 16 to 18 patients in each of the three categories were selected for chart abstraction to total 50 patients. We limited the chart review to a sample of 50 patients due to time and resource constraints of research study. We created a chart abstraction template to organize information pertaining to Pap, HPV, or co-testing, test results, and whether screening was completed within the indicated time frame of the previous screening. For follow-up of results, we tracked whether results were communicated to patients, referrals to specialists were sent, and communication from specialists. Screening concordance was determined using USPSTF guidelines for the average risk group. Follow-up concordance was determined using the 2019 ASCCP Risk-Based Management Consensus Guidelines for the average-to-high- and high-risk groups. Results Survey participants (N = 24) included 54% clinic staff and 46% providers (Table 1). More than half of participants (54%) had worked in their current role for less than five years, indicating high staff turnover and opportunities for clinic staff training. Table 1Characteristics of survey participants and HPV & cervical cancer measures (n = 24)CharacteristicProvidersClinic Staffn (%)n (%)Total11 (45.8)13 (54.2)Number of clinic locations participants work 1 site7 (63.6)12 (92.3) 2 or more locations4 (36.4)1 (7.7)Years worked in current or similar position < 1 year2 (18.2)1 (7.7) 1–4 years4 (36.4)6 (46.2) 5–9 years2 (18.2)2 (15.4) 10–14 years1 (9.1)2 (15.4) 15–19 years2 (18.2)0 (0) ≥ 20 years0 (0)1 (7.7) missing-1 (7.7)Role in cervical cancer screening Schedule appointments2 (18.2)1 (7.7) Refer patients out4 (36.4)6 (46.2) Call patients to deliver test results2 (18.2)2 (15.4) Document cervical cancer screening1 (9.1)2 (15.4) Other2 (18.2)1 (7.7) Mean (# of items) Mean (# of items) HPV and cervical cancer scales HPV knowledge^6.45 (7)4.85 (7) Cervical cancer screening knowledge^5.27 (7)4.23 (7) Confidence to address patient questions about cervical cancer screening^2.33 (3)1.17 (3) Readiness to improve cervical cancer screening3.33 (5)3.45 (5)Fisher’s exact t-tests compared differences between provider and staff. ^ indicates p<0.05 Characteristics of survey participants and HPV & cervical cancer measures (n = 24) Fisher’s exact t-tests compared differences between provider and staff. ^ indicates p<0.05 Providers demonstrated significantly higher HPV knowledge (92% vs. 69%, p < 0.05) and cervical cancer screening guideline knowledge (67% vs. 49%, p < 0.05) compared to clinic staff (Fig. 1). To assess knowledge of recommended cervical cancer screening guidelines, participants were asked how often patients should receive screening if they only receive an HPV test. Compared to 94% of providers reporting high confidence in their ability to address patient concerns about cervical cancer screening, only 36% of clinic staff felt confident addressing the same questions (p < 0.05). Low confidence among staff indicated a potential to provide education and training to the clinic team as an implementation strategy to support screening communication and workflows. Provider and clinic staff knowledge and confidence in HPV and cervical cancer In terms of implementation opportunity, approximately 96% of providers and clinic staff strongly agreed or agreed their clinic would benefit from new strategies to improve cervical cancer screening and follow-up referral for patients. More than three-fourths (77%) of clinic team members also strongly agreed or agreed that their clinic is prepared to implement new cervical cancer screening strategies. A total of 23 participants, including 9 system leaders, 9 clinic staff, and 5 providers, completed qualitative interviews (Table 2). We organized themes across the inner setting, outer setting, individual, innovation, and implementation process domains below. Table 2Characteristics of qualitative interview participants (N = 23)Characteristicn (%)Location Clinic 14 (17.4) Clinic 23 (13.0) Clinic 34 (17.4) Clinic 43 (13.0) System9 (39.1)Role Provider (MD, NP)5 (21.7) Clinic Staff (MA, LVN)9 (39.1) System Leader9 (39.1)Gender Female17 (73.9) Male5 (21.7)Clinic tenure 1–5 years5 (22.7) 6–10 years17 (77.3) > 10 years2 (8.7)Age 18–29 years5 (21.7) 30–39 years4 (17.4) 40–49 years8 (34.8) 50–59 years4 (17.4) 60–69 years2 (8.7)Race/ethnicity Asian/Asian American18 (78.3) Hispanic/Latina4 (17.4) White1 (4.3)Language spoken other than English Cantonese14 (36.8) Mandarin15 (39.5) Burmese2 (5.3) Spanish7 (18.4) Characteristics of qualitative interview participants (N = 23) Inner setting Barriers to cervical cancer screening, follow-up and referral within the FQHC setting included lack of system-level guidance on cervical cancer screening guidelines and the need for systematically documenting screening results and guideline-directed follow-up care. Theme 1: establishing standardized system-level screening guidelines can reduce provider and clinic variability in screening practices Participants described notable heterogeneity in screening practices across clinic sites and providers, driven in part by lack of formal system-level guidance regarding which professional society guidelines to adopt. While many providers describe co-testing as standard practice for screening their patients, others modified screening modality and frequency based on patients’ risk behaviors. For example, one provider said, “Some of the people, they have a safe sex practice, we don’t add HPV testing. But if they have a certain high-risk behavior – multiple sexual partners, that is a high-risk behavior. Or maybe they have a history of abnormal pap smear. Then, we will include that HPV [test] all the time.” (Clinic1_Provider). Another provider described repeating screening tests annually despite prior results, “If it was normal last year, they still want to repeat it this year, I’m okay with doing it as well, because if they ask, I’ll do it.” (Clinic1_Provider). System leaders confirm limited FQHC-level guidelines on recommended screening guidelines. One system leader stated, “[The system] doesn’t have a recommended guideline…we just let the providers follow what they want.” (System Leader) Another system leader emphasized concerns that highly directed guidelines could negatively impact provider autonomy, “We let the providers make their own decisions…The problem is that if you have a guideline for everything, I think it affects the ability of providers to feel like they have any autonomy on making decisions.” Clinic staff also described uncertainty trusting current cervical cancer screening guidelines. When discussing cervical cancer screening guidelines that vary between every three years and every five years one clinic staff stated, “I feel five years is way too long for the human body. Everything could be changed right away.” (Clinic2_Staff). Collectively, these findings suggest a current lack of standardized, system-endorsed screening guidance, leading to practice variation and inconsistent adherence to screening intervals based on risk and prior screening results. Provider variation in particular could limit performance across clinics in reaching optimal screening uptake and outcomes. Theme 2: current quality improvement infrastructure and health information systems limit tracking and evaluation of cervical cancer screening and follow-up of screening results Providers highlighted limited existing systems for tracking patients who are due for screening and follow-up, resulting in missed screening opportunities and potentially delayed care. One provider explained, “If they [patients] don’t return for their appointment when it’s time, we can lose track of them,” and further noted “We don’t have the system [to track]. They [healthcare system] needs that system [tracking tool].” (Clinic4_Provider). System-level leaders emphasized the need for structured, team-based quality improvement processes to address these gaps. One leader highlighted the importance of “a team process where we’re harnessing the knowledge, the skills of those doing the reporting processes…teamwork is important to QI because the processes and the systems are all very complex …” (System Leader) The system leader further underscored that engaging multiple departments and securing staff commitment and stakeholder buy-in were essential for developing feasible solutions related to cervical cancer screening improvement. These perspectives suggest FQHC capacity for tracking patients and current QI processes may limit the FQHC’s ability to monitor screening uptake, ensure follow-up, and stay current with evolving screening guidelines. Outer setting Outer setting barriers included logistical and structural obstacles that patients encounter when referred to a gynecology and obstetrics specialist following an abnormal Pap test result. Providers and clinic staff noted long wait times for approval of referrals and difficulty referring to language-concordant providers, while patients reported transportation issues to the referred specialist’s office and difficulty finding a specialty physician accepting new patients. Theme 3: managed care network constraints and administrative referral requirements delay timely follow-up after abnormal screening results Providers and clinic staff noted that referral appointments can take weeks to months, contributing to patients’ worry after receiving an abnormal result and delay appropriate follow-up care. One staff member explained “[Referral] appointments sometimes can take a while, so patients will be may be a little bit freaked out because they’re like, ‘I have an abnormal Pap, and I have to follow up with a specialist’, but they can’t be seen until a month or two later.” (Clinic3_Staff). Clinic staff noted difficulty navigating specialty care access within Medicaid managed plans, and specifically the network of private doctors that are contracted with Medicaid managed care plans, referred to as Medicaid Independent Physician Association (IPA). A clinic staff member explained, “I have so much difficult time when I choose somebody. ‘Oh, we don’t take even this. Oh, I’m not taking any patients. I don’t take insurance. The [healthcare system] need more updates [to IPA lists.” (Clinic2_Staff) When asked what potential changes can improve patient barriers accessing referrals, one provider said “We cannot change. Insurance must change. The IPA must change. I cannot change anything. You know? Because in this insurance, I cannot change anything…especially for the Medicaid…under the managed care, they have their own IPA.” (Clinic1_Provider) When asked ways in which to support patients with long wait times, one provider stated, “I just keep doing their [Pap tests] every six months. So at least I can inspect it, and look at it, and see if there’s any changes in pathology reports. They need more than that, but that’s what I do.” (Clinic3_Provider). Theme 4: need for strengthening linguistically appropriate communication and referral navigation to improve receipt of screening results and referral to follow-up care Participants described non-English-speaking patients prefer providers to speak their language and encounter difficulties making appointments with clinics that do not have accessible language resources. When asked to describe common concerns of patients related to cancer screening, one system leader said, “A lot of the times, it might be we hear that they don’t have enough appointments available at the specialist clinic or their staff at the specialist clinic don’t speak their language. So, we try to redirect them to another specialist that can offer what they need.” (System Leader) Similarly, another clinic staff member noted, “Once the authorization has been approved, then you [patient] call and schedule your appointment. Some patients are very, like, ‘oh, I can’t get to them [provider]’. Especially if they speak…a lot of Asian [patients]…if the provider …doesn’t speak their language, it’s very hard for them to communicate. I mean, I think it goes same with Hispanic [patients] because they speak Spanish.” (Clinic1_Staff) To overcome this, FQHC clinic staff described their role in assisting with patients’ language barriers when seeking care outside of the FQHC, “If I’m able to help, I’ll go ahead and schedule the appointment for them…or another one of our staff will do that…There’s always someone in-house that speaks the language.” In addition to language, participants described transportation issues. When asked about barriers patients encounter with cervical cancer follow-up appointments, one staff said, “They need language [services] a lot. They need transportation. They need your help [to] make appointments. Everything.” (Clinic2_Staff). Collectively, these findings indicate that insurance network constraints, administrative referral requirements, limited linguistically concordant specialty access, and limited referral navigation infrastructure can contribute to barriers and disruptions to timely diagnostic resolution and follow-up after abnormal cervical cancer screening. Individual characteristics In this FQHC serving a diverse patient population of Asian American and Hispanic patients, clinic team members highlighted that patients who were not currently sexually active and older patients often perceive their risk as low and decline testing. In addition, cervical cancer screening is delayed when addressing complex clinical and social conditions of patients within the FQHC. Theme 5: patients’ sexual history and perceived risk of cervical cancer can influence their decision on whether to receive routine screening Providers described how patients’ sexual history can influence willingness to screen with many noting that patients who have abstained from sex may refuse cervical cancer screening due to discomfort and embarrassment. One provider stated, “Pain, embarrassment. And the ones who have never been sexually active, they just don’t want to be touched there.” (Clinic3_Provider) Another provider also stated Pap test refusal is sometimes attributed to no sexual encounters, “I have a patient for a physical due for a Pap… the reason why she didn’t want to get it done is because she said she wasn’t sexually active.” That same provider said their messaging to patients reluctant to screen due to lack of sexual activity, “You’re due for a Pap. Usually, we start at age 21 regardless of sexual encounter, and then, we do it up until age 65. I understand that you don’t want do it today because you never had sexual activity. However, those who have a cervix are potentially at risk of cervical cancer,” and then, I just explain like that. I let them know… you have a cervix, you potentially can have cervical cancer.” (Clinic1_Provider). Patient perceived risk is sometimes influenced by new sexual encounters. One provider stated, “Sometimes, they tell me if they have a new sexual partner or they’re engaging in more risky behavior, they want to get it done. Some people, just for ease of mind” (Clinic1_Provider). Clinic staff also noted lower screening among older patients, “A majority of the [clinic] population is a lot older. So, there’s not much patients that are scheduled for Pap smears unless they’re a little bit younger or their still going through their menstrual cycle. (System Leader) Theme 6: multiple competing health concerns for some patients create challenges for integrating cervical cancer screening into patient visits Patients who underutilize health care may experience delays in cervical cancer screening as urgent health concerns take priority during doctor’s visits. One provider said, “Given our patient population, by the time they see me, even the first visit, they have a lot of concerns. At least five to ten complaints depending on the person. And it’s difficult to address everything. I feel like they might hold off on the screening and address their main concerns…their arm is hurting…hypertension uncontrolled…” (Clinic1_Provider) A system-level leader also acknowledged limited time with patients can contribute to delay in prioritizing screening, “Sometimes the providers when they see the patients, they have limited time. Sometimes they cannot address all the Care Gaps. So, they may not have enough time to address cancer screening during that five- or ten-minutes patient visit.” (System Leader). Innovation Facilitators to cervical cancer screening included high motivation among clinic leaders, providers and staff to increase cervical cancer screening. Innovative strategies included expanding geographic and linguistically concordant gynecology specialists available in partnership with payers and community partners and increasing community cervical cancer awareness and improving communication strategies through community partnerships. Theme 7: high motivation among clinic leaders, providers and staff to increase cervical cancer screening and follow-up Participants described personal and system-level motivation to improve cervical cancer screening and follow-up. When asked about how their clinic prioritizes cervical cancer screening, one system leader said, “Cervical cancer screening is always one of our major concerns .” (System Leader) Another system leader mentioned, “From a personal level my mother also had cervical cancer about 20 years ago when I was younger, and it has affected me. So, it’s something that I hold near and dear to my heart just to make sure.” (System Leader) When asked about practice change that can occur to support cervical cancer screening, this same system leader said, “[There’s] a chaotic process to get data, and I want it to be at the fingertips of all of our staff, regardless of the title, the position. I want people to look at that data and then engage with it in a live manner.” Provider noted additional tasks they take on to support abnormal follow-up services. One highly motivated provider noted they created an internal process of following up with their patients, “Specifically [for] abnormal pap. Yeah, it is the follow-up log for me, this the book I created. So, I created – I teach my nurses. We are very forgetful.” (Clinic1_Provider) Another provider motivated to reduce time to follow-up services by ensuring patients know as soon as referrals have been approved, “Patients have to wait two weeks or longer for the referral to come, and I think that causes a lot of anxiety, so that’s why I try to write in my notes, ‘Oh, please email the patient or call them once the authorization is approved.’” (Clinic1_Provider). Clinic staff noted motivation when communicating with patients regarding screening, “It’s an important test. We will do this exam until 65 years old. If the patient strongly refuses…we explain to the patient and then encourage them to do it.” (Clinic1_Clinic Staff). Theme 8: leveraging community partnerships and culturally responsive communication strategies can improve screening uptake Participants described existing FQHC volunteers and contract workers to provide services that address cultural barriers. However, community partnerships and collaborations for cancer prevention and control were hardly mentioned. When asked to describe the patient population, a system leader stated, “A lot of the patients that we serve – they’re immigrants… so there’s a lot of terminology that [patients] use when they discuss their history that is difficult for me to understand.” In addition to cultural barriers, on staff identified a communication barrier attributed to cultural and age norms, “Patients don’t receive the letters from healthcare providers. And then, since they’re from the older population… they don’t have any email addresses” (Clinic3_Staff) One system leader spoke about creating engaging tools that can address cultural barriers, “after talking to several clinicians that our API populations have a really hard time of doing and completing these screenings due to cultural issues. And so, we at the organization talk a lot about these measures on how to engage with our patients and look to our clinicians on leadership on how we can develop engagement tools to be able to effectively bring the cancer screening rates higher than what we’ve been doing previously” (System Leader). Many participants described community outreach events and health fairs as strategies to reach their diverse patient population. Implementation process Activities and strategies to support clinic capacity and cervical cancer screening included the need for provider and staff training on cervical cancer screening guidelines. Theme 9: system-level interest to increase the capacity to systematically track cervical cancer screening results and follow-up to improve guideline-concordant follow-up care Participants noted that current tracking of cervical cancer screening patterns and follow-up needs were dependent on activities of an under-resourced quality improvement (QI) team. When describing current clinic initiatives, one system leader stated, “They’re not year-long projects because we don’t really have a QI team. A lot of other agencies like FQHCs, they would have an actual QI team of like 6 to 10 people who are doing the work versus our QI team is like three providers.” (System Leader). Participants also described gaps in tracking cervical cancer screening results. Providers described challenges with new patients who must sign a medical release form to obtain older medical records. Patient barriers were also raised, “They don’t remember the name of the clinic, they don’t remember the provider… possibly because they moved a lot or they are from a different country. ” (Clinic1_Provider) One provider described the need to ask patients their history, “I ask them- ‘When was your last Pap?’ and ‘What were the results?’ If they are unsure, I always offer [the screening].” (Clinic1_Provider). Participants described when patients were seen by specialists outside of the FQHC there was difficulty with closed-loop communication between the FQHC and specialists, as providers and staff documented many attempts to receive reports. One provider mentioned challenges receiving results after referral to specialists. “Some of the specialists, after they see the patient…they don’t send me the progress notes, so I don’t know what is happening.” (Clinic1_Provider). Theme 10: system leader and provider support to implement training for clinic staff to improve cervical cancer screening workflow and outcomes Providers described the opportunity for clinic staff to become more proficient in cervical cancer screening guidelines, “I want [clinic staff] to know when, at what age should be doing what, and how often. Because sometimes they’ll go in, and have the patient get all undressed, and they don’t need a Pap. Or sometimes when they’re due for a Pap, and they don’t pick it up, and then I must waste my time, get out of the room, tell them to undress. And they get it done. So, it’s just a time issue.” (Clinic3_Provider). Similarly, system leaders expressed similar perspectives, “[We are hoping] to have more individuals engaged, trained, and then through this collaboration to get some of those clinical expertise to actually have all our staff, frontline staff, be able to understand how important cervical cancer screening is” (System Leader) Clinic staff acknowledged no clinic-based cervical cancer trainings currently exist, “In the two years that I’ve been working here, I don’t think we’ve ever had a cervical cancer presentation.” (Clinic3_Clinic Staff). Electronic health records analysis A total of 1,428 eligible patient charts were identified during the retrospective electronic health record review period. From these, a random sample of 50 patient charts were selected to assess patterns of care across risk categories: average risk (n = 16), average-to-high risk (n = 16), and high risk (n = 18) (Table 3). Overall, 48% of sampled charts demonstrated guideline-discordant screening or follow-up care. Among patients categorized as average-to-high risk or high risk, discordance included delayed referral to specialty care, follow-up care that differed from guideline-recommended management (e.g., Pap testing in place of co-testing), and absence of documented follow-up after abnormal screening results. In analyzing patterns of care, lack of specialty visits availability or insurance acceptance led to challenges accessing specialty care for some patients. Table 3Follow-up characteristics of patients receiving ≥ 1 cervical cancer screening, January 1, 2020-March 31, 2023Follow-up characteristics by risk group n Average Risk (n = 16) Unknown3 Guideline-concordant follow-up4 Guideline-discordant follow-up, subtotal9 Over-screening = occurred ≥ 6 months before due or when not indicated 7 Under-screening = occurred ≥ 6 months after due or not at all 2 Above Average to High-Risk Group (n = 16) Unknown2 Guideline-concordant follow-up6 Guideline-discordant follow-up, subtotal8 Delayed Care = Received indicated follow-up past indicated time frame 1 Discordant Care = Received follow-up that was different than what was indicated 2 No Care = Did not receive follow-up, results not shared 5 High-Risk Group (n = 18) Unknown2 Guideline-concordant follow-up9 Guideline-discordant follow-up, subtotal7 Delayed Care = Received indicated follow-up past indicated time frame 3 Discordant Care = Received follow-up that was different than what was indicated 1 No Care = Did not receive follow-up 3 Follow-up characteristics of patients receiving ≥ 1 cervical cancer screening, January 1, 2020-March 31, 2023 Additionally, chart reviews identified substantial gaps in adherence to evidence-based cervical cancer screening and management guidelines, particularly among patients requiring higher-risk follow-up, suggesting the presence of multilevel barriers to timely and guideline-concordant care. Findings from integrated data Collectively, the quantitative, qualitative, and electronic health record (EHR) findings revealed convergence across data sources, demonstrating that gaps in guideline-concordant cervical cancer screening and follow-up were driven by multilevel determinants. Quantitative survey results identified gaps in between providers and clinic staff in cervical cancer screening guideline knowledge and confidence in discussing cervical cancer screening with patients. Qualitative findings contextualized these gaps, noting the absence of standardized system-level screening protocols, needs for improvement infrastructure and tracking mechanisms, and uncertainty regarding evolving guideline intervals. These inner setting barriers help explain observed variability in screening practices across providers and clinic sites. Outer setting qualitative data highlighted structural barriers, including Medicaid managed care network constraints, referral authorization delays, limited linguistically concordant specialty access, and transportation challenges that impact delays in care. These reported barriers were further supported by EHR findings, where nearly half of reviewed charts demonstrated guideline-discordant care, particularly among higher-risk patients requiring specialty referral and follow-up. Documentation gaps and incomplete closed-loop communication with specialists observed in chart reviews mirror perspectives in opportunities for building capacity in tracking systems and referral navigation processes. Discussion In this mixed-methods assessment of a multi-site urban FQHC serving predominantly Asian American and Hispanic communities, we identified multilevel determinants influencing cervical cancer screening, follow-up, and referral processes. Our findings are consistent with prior studies demonstrating that FQHC patients experience lower rates of guideline-concordant cervical cancer screening and timely follow-up after abnormal results compared with patients in other care settings [15, 21]. Specifically for screening, patient-level barriers included low perceived risk among older and sexually inactive patients, structural barriers to language-concordant providers, transportation challenges, and competing clinical needs. At the provider and clinic staff level, gaps in knowledge regarding screening guidelines, particularly among non-provider staff, were influenced by limited visit time, high staff turnover, and lack of standardized system-level screening protocols. Variability in provider adherence to screening guidelines, awareness of cervical cancer and community-related barriers, and clinic staff familiarity with cervical cancer screening guidelines further impact optimal cervical cancer prevention in FQHCs. Recent updates to the American Cancer Society and HRSA screening guidelines to HPV testing and self-sampling may provide an opportunity to close screening gaps with increased accessibility but will also require community awareness and clinic team education [1, 27–30]. These findings reinforce the need for system-level supports, including standardized guidelines, EHR-enabled decision support, and risk-based management tools such as the ASCCP web-based calculators and patient-facing platforms (e.g., cervicalrisk.com), which may reduce practice variation and support evidence-based care across diverse clinical teams. Importantly, this study extends existing literature by highlighting how payer structures and local Medicaid managed care IPA network limitation intersect with language and cultural barriers to exacerbate delays in follow-up care. Overall, barriers were more prevalent in follow-up and referral steps at the system-level, including limited access to specialty referral networks, overall delays in referrals to specialists, and inadequate closed-loop communication between FQHCs and specialty care contributed to substantial guideline-discordant care. These qualitative findings could help explain the large proportion of patients who received guideline-discordant follow-up care based on our chart review assessment. Nearly half of reviewed charts demonstrated deviations from recommended screening or follow-up, underscoring how structural and workflow barriers translate into measurable care gaps for medically underserved populations. Furthermore, while FQHCs and other community partner organizations have focused on addressing screening-related barriers, fewer strategies are in place to systematically track follow-up needs and facilitation and navigation to referrals beyond the primary care setting. Implementation planning for evidence-based interventions (EBIs) in FQHC settings must be aligned with clinic capacity and local community context, developed through sustained partnerships between FQHCs, cancer centers, payers, and community organizations. Patient navigation and culturally tailored education have emerged as effective strategies to address barriers across the screening continuum, from outreach and education to referral completion and follow-up. Prior research demonstrates that patient navigation can significantly reduce time to diagnostic resolution and treatment, especially for populations facing linguistic and logistical barriers [31, 32]. Our findings suggest that integrating navigation with enhanced EHR tracking, team-based quality improvement infrastructure, and training for both providers and frontline staff could improve screening adherence and follow-up completion for FQHC settings. Additionally, leveraging community partnerships and outreach may help reduce stigma and normalize cervical cancer prevention among immigrant and guideline-specific patient populations [33, 34]. Through the 2022 Cancer Moonshot Initiative, the Federal Cervical Cancer Collaborative was established to improve equitable cervical cancer control in safety-net settings, including a landscape analysis identifying key facilitators and barriers to cervical cancer screening in low resource settings [35]. Several evidence-based interventions, including patient navigation and outreach, EHR tracking systems and provider reminders, provider and clinic staff training, culturally tailored education for communities, and patient reminders, are effective in improving cervical cancer screening within clinic settings [22, 36]. However, interventions must be designed to fit the limited resources and high provider and staff turnover and burnout in FQHC settings for them to be feasible and sustainable [37–40]. This study has some limitations. Findings are derived from a single FQHC system and a convenience sample of staff, providers, and patient charts, which may limit generalizability. Specifically, our study found inner setting barriers, such as scheduling follow-up visits and referrals, are managed solely at the system level. Providers and staff did not play a role in these responsibilities. These findings may not be generalizable to clinics that allocate these responsibilities to clinical members. Additionally, the retrospective chart review relied on documentation that may not fully capture patient-provider communication or external specialty care processes and focused on a subset sample of eligible patients. Despite these limitations, this study offers important insights into how structural inequities, evolving screening guidelines, and fragmented referral systems converge in real-world primary care settings. Conclusions As the landscape of cervical cancer prevention continues to shift, with expanded HPV vaccination strategies and the integration of HPV self-sampling, partnerships between FQHCs and comprehensive cancer centers represent a critical pathway for advancing health equity. Persistent disparities in cervical cancer are a marker of structural barriers [41]. Recent federal policies, including the 2025 Federal Medicaid eligibility changes, which are forecasted to lead to 1 million missed cancer screenings [42], and ongoing federal immigration enforcement [43] which exacerbate patient fears of seeking health care services, suggest that current trends in cervical cancer screening for patients served in safety-net health care settings may be further jeopardized. Future work should focus on co-designing, implementing, and evaluating implementation strategies that are responsive to local context while scalable across safety-net health systems, which include working with Medicaid managed care programs to expand access to specialists for follow-up care. Notably, in the time following this partnership, this FQHC system hired their own gynecologist, facilitating access to their patients’ follow-up needs. Supporting FQHCs in implementing effective cancer prevention and screening strategies by building on their strengths in community engagement and integrated clinical and social services may enable partnerships to navigate current federal policy uncertainty. Our findings highlight the critical role of primary care teams in translating evolving screening guidelines into equitable practice and underscore the need for community and population-specific, evidence-based approaches such as education for patients and clinic teams, patient navigation, and system-level tracking systems. Strengthening partnerships between FQHCs and comprehensive cancer centers offers a scalable approach to disseminating and sustaining innovations in cancer screening, with potential to improve access, adherence, and early detection for populations disproportionately affected by cervical cancer disparities. Supplementary Information Supplementary Material 1 Supplementary Material 2 Acknowledgements We thank Emily Dang, Alejandra Ramos, Zehui He, Allison Oh, and Sz-Ying Lee for their contributions to data collection and community outreach. Abbreviations Advanced Practice Provider American Society for Colposcopy and Cervical Pathology Accelerating Cancer Screening Consolidated Framework for Implementation Research Evidence–Based Intervention Electronic Health Record Federally Qualified Health Center Human Papillomavirus Health Resources and Services Administration Independent Physician Association Doctor of Medicine National Cancer Institute Norris Comprehensive Cancer Center Qualitative Data Analysis Software (NVivo version 1.7.1) Papanicolaou (test) Quality Improvement United States Preventive Services Task Force Authors’ contributions JT and JC developed study design and secured funding of the study. SG and KL collected the data. JT, SG, MS, KL, MG analyzed and interpreted study data and drafted and revised the manuscript. AC, GH, and JC contributed to interpretation of study findings and revisions of manuscript. CHH, LGB, XMG, and contributed to interpreting the data, drafting and revising the manuscript. All authors read and approved the final manuscript. Funding This study was supported in part by HRSA award 1 H8ICS46988-01-00 (PI: Cheng). Data availability The dataset generated and analyzed in this study is not publicly available because of the detailed nature of this qualitative data, which could compromise participant anonymity. For more information on qualitative and survey data email the corresponding author. Participant EHR data will require permission from FQHC partner (email: jacheng@cscla.org). Declarations Ethics approval and consent to participate This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and its subsequent amendments. This study was approved by the University of Southern California Institutional Review Board (UP-23-00185). Interview participants completed a signed written informed consent form. Consent for publication Not Applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Data Availability Statement The dataset generated and analyzed in this study is not publicly available because of the detailed nature of this qualitative data, which could compromise participant anonymity. For more information on qualitative and survey data email the corresponding author. Participant EHR data will require permission from FQHC partner (email: jacheng@cscla.org).